These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
105 related articles for article (PubMed ID: 36337370)
1. Analysis of serious adverse events reports: Review by an Institutional Ethics Committee of a tertiary care teaching hospital. Dakhale GN; Kalikar MV; Giradkar AB; Sinha VV Perspect Clin Res; 2022; 13(4):189-193. PubMed ID: 36337370 [TBL] [Abstract][Full Text] [Related]
2. Serious Adverse Events Reports: Analysis and Outcome of Review by an Institutional Ethics Committee of a Tertiary Care Hospital in Mumbai, India. Tripathi RK; Marathe PA; Kapse SV; Shetty YC; Kamat SK; Thatte UM J Empir Res Hum Res Ethics; 2016 Jul; 11(3):267-73. PubMed ID: 27353243 [TBL] [Abstract][Full Text] [Related]
3. Onsite serious adverse events reporting: Seven-year experience of the institutional ethics committee of a tertiary care hospital. Shetty YC; Auti PD; Aithal YR Perspect Clin Res; 2024; 15(3):134-140. PubMed ID: 39140018 [TBL] [Abstract][Full Text] [Related]
4. Ethics of Safety Reporting of a Clinical Trial. Sil A; Das NK Indian J Dermatol; 2017; 62(4):387-391. PubMed ID: 28794549 [TBL] [Abstract][Full Text] [Related]
5. Audit of principal investigator's compliance for submission of continue review application and decisions taken on lapses in validity of approval by the Institutional Ethics Committee at tertiary oncology center in Navi Mumbai. Bandekar B; Awatagiri K; Kannan S; Rane P; Parikh P Perspect Clin Res; 2022; 13(3):145-150. PubMed ID: 35928644 [TBL] [Abstract][Full Text] [Related]
6. Streamlining electronic reporting of serious adverse events (SAEs) using the REDCap data collection system: the eSAE Project. Black J; Julier P; Eldridge L; Barber VS Trials; 2024 Jul; 25(1):503. PubMed ID: 39044237 [TBL] [Abstract][Full Text] [Related]
7. Academic Clinical Trials Submitted to an Institutional Ethics Committee at a Tertiary Care Center: A Retrospective Analysis. Shetty YC; Aithal YR; Katkar J; Naik M Cureus; 2024 Feb; 16(2):e53476. PubMed ID: 38440003 [TBL] [Abstract][Full Text] [Related]
8. An evaluation of knowledge, attitude, and practice of institutional ethics committee members from eastern India regarding ethics committee functioning and pharmacovigilance activities conducted during clinical trials: A pilot study. Bhowmick S; Banerjee K; Sikdar S; Chatterjee TK Perspect Clin Res; 2014 Jul; 5(3):115-20. PubMed ID: 24987581 [TBL] [Abstract][Full Text] [Related]
9. Inhaled steroids with and without regular formoterol for asthma: serious adverse events. Janjua S; Schmidt S; Ferrer M; Cates CJ Cochrane Database Syst Rev; 2019 Sep; 9(9):CD006924. PubMed ID: 31553802 [TBL] [Abstract][Full Text] [Related]
10. Patient reporting of sexual adverse events on an online platform for medication experiences. Gordijn R; Wessels W; Kriek E; Nicolai MPJ; Elzevier HW; Visser L; Guchelaar HJ; Teichert M Br J Clin Pharmacol; 2022 Dec; 88(12):5326-5335. PubMed ID: 35778921 [TBL] [Abstract][Full Text] [Related]
11. Under-reporting of maternal and perinatal adverse events in New Zealand. Farquhar C; Armstrong S; Kim B; Masson V; Sadler L BMJ Open; 2015 Jul; 5(7):e007970. PubMed ID: 26204910 [TBL] [Abstract][Full Text] [Related]
12. Reports of site monitoring visits by institutional ethics committees in an Indian tertiary care hospital: A retrospective analysis. Shetty YC; Singh KNM; Marathe PA; Jalgaonkar SV; Gajbhiye S; Katkar J; Vengurlekar MU Indian J Med Ethics; 2019; 4(3):178-183. PubMed ID: 31727613 [TBL] [Abstract][Full Text] [Related]
13. Assessment of Knowledge and Awareness Among the Stakeholders of Clinical Research at the Site: A Collaborative, Electronic-Survey Approach to Identify the Indicators of Quality. Pal C; Rengan AK; Moodahadu L; Swaminathan J; Nagalla B Rev Recent Clin Trials; 2023; 18(1):56-68. PubMed ID: 36278456 [TBL] [Abstract][Full Text] [Related]
14. Reporting of serious adverse events during cancer clinical trials to the institutional review board: an evaluation by the research on adverse drug events and reports (RADAR) project. Belknap SM; Georgopoulos CH; Lagman J; Weitzman SA; Qualkenbush L; Yarnold PR; Edwards BJ; McKoy JM; Trifilio SM; West DP J Clin Pharmacol; 2013 Dec; 53(12):1334-40. PubMed ID: 24030903 [TBL] [Abstract][Full Text] [Related]
15. Impact of recent regulatory notifications on an institutional ethics committee. Bhide SS; Jalgaonkar SV; Katkar JV; Shetty YC; Tripathi RK; Marathe PA; Thatte UM Indian J Med Ethics; 2016; 1(4):210-214. PubMed ID: 27473067 [TBL] [Abstract][Full Text] [Related]
16. Projects not initiated by investigators: a retrospective analysis of the queries raised by the institutional ethics committees of a teaching hospital. Kuyare SS; Marathe PA; Shetty YC; Kamat SK; Katkar JV; Thatte UM J Postgrad Med; 2014; 60(1):46-50. PubMed ID: 24625939 [TBL] [Abstract][Full Text] [Related]
17. Opinions and perceptions regarding the impact of new regulatory guidelines: A survey in Indian Clinical Trial Investigators. Kadam R; Borde S; Madas S; Nagarkar A; Salvi S; Limaye S Perspect Clin Res; 2016; 7(2):81-7. PubMed ID: 27141474 [TBL] [Abstract][Full Text] [Related]
18. In-hospital mortality after serious adverse events on medical and surgical nursing units: a mixed methods study. De Meester K; Van Bogaert P; Clarke SP; Bossaert L J Clin Nurs; 2013 Aug; 22(15-16):2308-17. PubMed ID: 22827923 [TBL] [Abstract][Full Text] [Related]
19. Analysis of clinical trial agreement and insurance policy submitted to the ethics committee of a tertiary care teaching institute in central India. Kalikar MV; Dakhale GN; Sinha VV; Giradkar AB Perspect Clin Res; 2022; 13(3):151-154. PubMed ID: 35928639 [TBL] [Abstract][Full Text] [Related]
20. A Study of Assessing Errors and Completeness of Research Application Forms Submitted to Instituitional Ethics Committee (IEC) of a Tertiary Care Hospital. Shah PC; Panchasara AK; Barvaliya MJ; Tripathi CB J Clin Diagn Res; 2016 Sep; 10(9):FC10-FC12. PubMed ID: 27790458 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]